# Xofluza

NDC: 50242-877
Generic name: BALOXAVIR MARBOXIL
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20181024

FDA application: NDA210854

## Active ingredients

- BALOXAVIR MARBOXIL: 80 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-877"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-877
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e49e1a61-1b7c-4be5-ac84-af6240b511e7